As of Beijing time The data is from a third-party organization and is only for reference.
For actual information, please refer to：www.eastmoney.com
Address: 20 Maguire Road, Suite 103, Lexington, MA 02421(America)
Tel: +1(626)986-9880
Address: Allia Future Business Centre Kings Hedges Road Cambridge CB4 2HY, UK
Tel: 0044 7790 816 954
Email: marketing@medicilon.com
Address: No.585 Chuanda Road, Pudong New Area, Shanghai (Headquarters)
Postcode: 201299
Tel: +86 (21) 5859-1500 (main line)
Fax: +86 (21) 5859-6369
© 2023 Shanghai Medicilon Inc. All rights reserved Shanghai ICP No.10216606-3
Shanghai Public Network Security File No. 31011502018888 | Website Map
Business Inquiry
Global：
Email:marketing@medicilon.com
+1(626)986-9880(U.S.)
0044 7790 816 954 (Europe)
China：
Email: marketing@medicilon.com.cn
Tel: +86 (21) 5859-1500
Recently, Shanghai Medicilon was awarded the title of “Excellent Expert Workstation” by the Shanghai Academician and Expert Workstation Guidance Office and the title of “2020 Pudong New Area Excellent Academician and Expert Workstation” by the Pudong Science and Technology Association.
Medicilon was awarded the title of “Excellent Expert Workstation” by the Shanghai Academician Expert Workstation Guidance Office Medicilon was awarded the title of “2020 Pudong New Area Excellent Academician and Expert Workstation” by the Pudong Science and Technology Association Shanghai Medicilon builds and improves the R&D platform with the core concept of “innovation-driven, quality first” to ensure that high-quality scientific research resources are used to assist customers and many scientific researchers in new drug research and development projects.
For Medicilon, the double evaluation is both affirmation and encouragement. Medicilon will continue to work hard, not forget its original intention, continue to lean platform resources, improve service quality, and provide support and assistance to more new drug research and development workers. Watch the birth of a new drug!
Medicilon (stock code: 688202) was established in 2004 and is headquartered in Shanghai. It is committed to providing a full range of preclinical new drug research services for global pharmaceutical companies, research institutions and scientific researchers. Medicilon’s one-stop integrated service helps customers accelerate the development of new drugs with strong project management and more efficient and cost-effective R&D services. The services cover the entire process of preclinical new drug research in medicine, including drug discovery, pharmaceutical research and clinical trials. Pre-research. Medicilon grows together with high-quality customers at home and abroad, and provides new drug research and development services to more than 700 customers around the world. Medicilon will continue to base itself on a global perspective, gather Chinese innovation, and contribute to human health!
contact us
Email: marketing@medicilon.com
Phone: +86 (21) 5859-1500
Relevant
news
marketing@medicilon.com
ABOUT
